Dr Reddy's launches lipid controlling drug in USA market

Pharma major Dr Reddy's Laboratories today said it has launched Fenofibrate capsules, a therapeutic

RELATED ARTICLES

equivalent generic version of Antara capsules, in the USA market.

The drug which is indicated to reduce cholesterol and triglycerides (fatty acids) in the blood was approved by the United States Food & Drug Administration (USFDA), DRL said in a statement.

The Antara (fenofibrate) capsules brand and generic had U.S. Sales of approximately $74 Million MAT for the most recent twelve months ending in February 2014 according to IMS Health.

Dr Reddy’s Fenofibrate capsules, USP 43 mg is available in bottle counts of 30, and 130 mg are available in bottle counts of 30 and 90, the drug maker said.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Prabhu Express has trundled into town with a cargo of feel-good promises

    Railway minister Suresh Prabhu, punning on his own name, sought divine intervention more than once while delivering his maiden rail budget last Thursd

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Taslima Nasreen

The death of a liberal humanist

I first met Avijit Roy about 15 years ago. He ...

Purnendu Ghosh

Context is important in colour choices

Colours reflect power, optimism, warmth, emotion and balance. Colours are ...

Shona Adhikari

Art world celebrates two ‘new’ Cezannes

The focus moves once more to post-impressionist Paul Cezanne, who ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture